Pharma Intelligence Podcasts-logo

Pharma Intelligence Podcasts

Business & Economics Podcasts

Pharma Intelligence from Informa places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Informa is a leader in the field of healthcare industry information.

Pharma Intelligence from Informa places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Informa is a leader in the field of healthcare industry information.

Location:

United States

Description:

Pharma Intelligence from Informa places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Informa is a leader in the field of healthcare industry information.

Language:

English


Episodes

Cybin CEO: Big Pharma Can No Longer Sit On The Sidelines In Psychedelics

5/17/2022
Cybin CEO: Big Pharma Can No Longer Sit On The Sidelines In Psychedelics by Informa

Duration:00:13:54

Digital Health Roundup – AI Trends In Medtech; Exec Chats; FDA’s Digital Health Guru Steps Down

5/16/2022
In this month’s podcast, Medtech Insight's Reed Miller discusses iRhythm’s CEO Quentin Blackford’s vision for the company as it plans for expanding its remote cardiac monitoring and arrythmia diagnostics market. Marion Webb highlights conversations with ORCHA’s clinical lead Fatima Ahmed on the shortfall of trustworthy femtech apps and with medical robotic authority Moshe Shoham on the future of robotics. Barnaby Pickering introduces SpectralMD’s developed AI-augmented imaging system and...

Duration:00:07:39

Scrip’s Five Must-Know Things – 16 May 2022

5/15/2022
Scrip’s Five Must-Know Things – 16 May 2022 by Informa

Duration:00:14:35

Pink Sheet Podcast: FDA User Fee Bill Mark-Up, Postmarket Quality Requirements, Fewer Adcom Meetings

5/13/2022
Pink Sheet reporter and editors discuss the first mark-up of the House FDA user fee bill, the likelihood of more postmarketing quality requirements for drug manufacturers, and the significance of the shrinking number of FDA advisory committee meetings.

Duration:00:24:33

How Ex-Janssen India Chief Is Steering Bharat Serums’ Ambitions In Women’s Health

5/13/2022
Sanjiv Navangul, managing director and CEO, Bharat Serums and Vaccines, outlines, in a wide ranging interview, the firm’s gameplan to establish itself as a “force to reckon with” in women’s health - it goes beyond drugs and encompasses devices and potentially digital therapeutics as well. The former Janssen India chief also weighs in on the worrying industry-wide input cost escalation scenario and supply chain turbulence.

Duration:00:37:49

Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment

5/12/2022
Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment by Informa

Duration:00:23:40

Scrip’s Five Must-Know Things – 9 May 2022

5/8/2022
Scrip’s Five Must-Know Things – 9 May 2022 by Informa

Duration:00:11:43

Pink Sheet Podcast: House User Fee Bill, Push For OTC Naloxone, SCOTUS Overturning Roe v. Wade

5/6/2022
Pink Sheet reporter and editors and HBW Insight editor discuss FDA reforms in the new user fee reauthorization bill, additional industry inducements to market OTC naloxone, and the impact of a Supreme Court’s potential overturning of Roe v. Wade on the agency.

Duration:00:44:55

The Landscape Of Naloxone Access With HRT’s Michael Hufford

5/6/2022
In this episode, HBW Insight speaks to Michael Hufford, co-founder and CEO of Harm Reduction Therapeutics about the inaccessibility of naloxone, a life-saving opioid overdose antidote. Hufford unpacks on the history of naloxone access and explains why standing orders aren’t as helpful as they seem. We also explore the incentives for companies currently producing prescription naloxone to make the switch to OTC status—and why many of them have chosen not to. While the financial incentive may...

Duration:00:27:52

Which COVID Trends Are Here To Stay? With IQVIA Consumer Health’s Prasanna Pitale

5/3/2022
In this episode, HBW Insight chats with IQVIA Consumer Health’s Prisana Pitale about research the organisation has done on the recent self-care trends that will endure after COVID. Commissioning an external organisation to speak to industry leaders, Pitale points to wellness and prevention, Rx-to-OTC switch and naturals as drivers of long-term change in global consumer health markets. We also dig a bit deeper into sustainability and artificial intelligence, which we agree are important...

Duration:00:31:15

Pink Sheet Podcast: Young Children’s COVID Vaccines, Aduhelm Coverage Criticism, McKinsey Conflicts

4/29/2022
Pink Sheet reporter and editor discuss next steps in the development of COVID-19 vaccines for young children, complaints about CMS’s coverage decision for Aduhelm, and the congressional investigation of McKinsey’s FDA conflicts of interest.

Duration:00:37:52

The EU HTA Regulation: How It Threatens Device Launches And Where The Solutions Lie

4/29/2022
The EU HTA Regulation: How It Threatens Device Launches And Where The Solutions Lie by Informa

Duration:00:18:30

CEO Podcast – CANbridge’s James Xue Talks To Scrip On Plans And Strategy

4/26/2022
The CEO of Chinese biotech CANbridge talks to Scrip’s Brian Yang on a broad range of topics related to the company’s plans and strategy in this new series of audio interviews with senior biopharma executives in China.

Duration:00:48:08

Scrip’s Five Must-Know Things – 25 April 2022

4/24/2022
Scrip’s Five Must-Know Things – 25 April 2022 by Informa

Duration:00:13:15

Exploring The Intersection Of Skincare, AI, And Business With Sampo Parkkinen

4/22/2022
In this episode, HBW speaks to AI technology expert Sampo Parkkinen, CEO of Revieve. We discuss the importance of customization for businesses and consumers, the future of AI in the cosmetics industry, and the younger demographics that are most interested in brand personalization. Finally, we talk about Revieve’s space in the metaverse, and how businesses can leverage new technology to build relationships with their consumers.

Duration:00:23:33

Pink Sheet Podcast: COVID-19 Vaccine Boosters, Clinical Trial Diversity, FDA Returns To The Office

4/22/2022
Pink Sheet reporter and editors discuss CDC advisors’ views on COVID-19 vaccine booster policy, new FDA guidance to promote clinical trial diversity, and what some FDA employees are finding when they return to the White Oak headquarters.

Duration:00:32:27

Zydus Lifesciences MD Sharvil Patel On Rare Disease Focus, New Corporate Identity, COVID Vaccine

4/21/2022
Zydus Lifesciences’ (formerly Cadila Healthcare) managing director Sharvil Patel speaks to Scrip on a host of topics ranging from a focus on rare diseases to a fresh corporate identity and plans for launch of a two-dose version of the world’s first plasmid DNA vaccine that it developed against COVID-19. Patel also talks about his personal business journey as well as the importance of building organizational agility to deal with uncertainty that companies are increasingly having to deal with.

Duration:00:14:09

Q1 Consumer Health Earnings Preview, With HBW’s Malcom Spicer And Tom Gallen

4/19/2022
In this episode, HBW Insight editors look ahead to Q1 sales and earnings reports of the world’s largest consumer healthcare companies. We reflect on what has happened in the last 12 months during the COVID-19 pandemic, and what the next few months might bring for industry. The return of cough and cold, inflation and the war in Ukraine and OTC business spin outs are all major trends shaping the market right now.

Duration:00:29:05

Scrip’s Five Must-Know Things – 18 April 2022

4/17/2022
Scrip’s Five Must-Know Things – 18 April 2022 by Informa

Duration:00:12:41

Device Week, 13 April 2022 –Miach And Outset Exec Chats; Medtronic Updates Renal Denervation Trials

4/13/2022
In this edition of Device Week, Medtech Insight’s Marion Webb reviews her recent interviews with Martha Shadan, the CEO of Miach Orthopedics, and Outset Medical’s CEO Leslie Trigg. Reed Miller has an update on Medtronic’s long-awaited renal denervation technology. Listen to the podcast via the player below: The archive of Medtech Insight's Device Week and the rest of Informa Pharma Intelligence’s podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google...

Duration:00:11:17